MARKET

APM

APM

Aptorum Group Ltd
NASDAQ
0.9300
+0.0100
+1.09%
Closed 15:32 05/02 EDT
OPEN
0.9000
PREV CLOSE
0.9200
HIGH
0.9554
LOW
0.9000
VOLUME
15.36K
TURNOVER
--
52 WEEK HIGH
7.49
52 WEEK LOW
0.4600
MARKET CAP
6.64M
P/E (TTM)
52.84
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APM last week (0421-0425)?
Weekly Report · 6d ago
Weekly Report: what happened at APM last week (0414-0418)?
Weekly Report · 04/21 10:54
Aptorum Group Faces Nasdaq Bid Price Compliance Challenge
TipRanks · 04/16 20:29
Aptorum Group receives Nasdaq non-compliance notification
TipRanks · 04/16 16:35
Aptorum Group Receives Notification From Nasdaq Regarding Non-Compliance With Minimum Bid Price Requirement Of $1/Shr
Benzinga · 04/16 16:32
APTORUM GROUP LTD - CONSIDERING REVERSE STOCK SPLIT TO RESTORE COMPLIANCE
Reuters · 04/16 16:27
APTORUM GROUP LIMITED ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE DEFICIENCY
Reuters · 04/16 16:27
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 04/16 12:07
More
About APM
More
Aptorum Group Limited is a United Kingdom-based clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a novel molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, commercialization arm of the Singapore's Agency for Science, Technology and Research.
Recently
Symbol
Price
%Change
    APM
  • 0.9300
  • +1.09%

Webull offers Aptorum Group Ltd stock information, including NASDAQ: APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.